Bibliografias temáticas / Neuromuscular transmission / Artigos de revistas
Siga este link para ver outros tipos de publicações sobre o tema: Neuromuscular transmission.

Artigos de revistas sobre o tema "Neuromuscular transmission"

Autor: Grafiati
Publicado: 4 de junho de 2021
Última modificação: 31 de julho de 2024

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Neuromuscular transmission".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.

1

MacLean, Ian C. "Neuromuscular Transmission". Physical Medicine and Rehabilitation Clinics of North America 1, n.º 1 (novembro de 1990): 43–52. http://dx.doi.org/10.1016/s1047-9651(18)30745-9.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Parker, C. "Neuromuscular transmission". Postgraduate Medical Journal 74, n.º 870 (1 de abril de 1998): 255. http://dx.doi.org/10.1136/pgmj.74.870.255-a.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Torda, T. A. "Monitoring Neuromuscular Transmission". Anaesthesia and Intensive Care 30, n.º 2 (abril de 2002): 123–33. http://dx.doi.org/10.1177/0310057x0203000202.

Texto completo da fonte
Resumo:
Persistent neuromuscular blockade is not uncommon in the recovery room and contributes to postoperative morbidity and possibly mortality. The use of neuromuscular monitoring and intermediate rather than long-acting neuromuscular blocking drugs have been shown to reduce its incidence. Clinically available methods of detecting and quantitating neuromuscular blockade are reviewed. The writer concludes that such monitoring should be routine when neuromuscular blocking drugs are used.
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Beemer, G. H., e P. H. Goonetilleke. "Monitoring neuromuscular transmission". Current Anaesthesia & Critical Care 7, n.º 2 (abril de 1996): 101–6. http://dx.doi.org/10.1016/s0953-7112(96)80065-2.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Pascuzzi, Robert. "Disorders of Neuromuscular Transmission". Seminars in Neurology 24, n.º 02 (15 de julho de 2004): 137. http://dx.doi.org/10.1055/s-2004-830898.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Weissman, J. D. "Electromyography: Neuromuscular Transmission Studies". Neurology 39, n.º 8 (1 de agosto de 1989): 1141. http://dx.doi.org/10.1212/wnl.39.8.1141-b.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Meistelman, Claude. "Monitoring of neuromuscular transmission". Current Opinion in Anaesthesiology 6, n.º 4 (agosto de 1993): 720–25. http://dx.doi.org/10.1097/00001503-199308000-00024.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Wareham, Anthony C. "Neuromuscular function and transmission". Anaesthesia & Intensive Care Medicine 6, n.º 6 (junho de 2005): 203–5. http://dx.doi.org/10.1383/anes.6.6.203.65787.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Krendel, David. "Hypermagnesemia and Neuromuscular Transmission". Seminars in Neurology 10, n.º 01 (março de 1990): 42–45. http://dx.doi.org/10.1055/s-2008-1041252.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

WINDSOR, J. P. W., P. S. SEBEL e P. J. FLYNN. "The neuromuscular transmission monitor". Anaesthesia 40, n.º 2 (22 de fevereiro de 2007): 146–51. http://dx.doi.org/10.1111/j.1365-2044.1985.tb10705.x.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
11

Henning, R. H. "Purinoceptors in neuromuscular transmission". Pharmacology & Therapeutics 74, n.º 1 (janeiro de 1997): 115–28. http://dx.doi.org/10.1016/s0163-7258(97)00015-6.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
12

Fletcher, Allan. "Neuromuscular function and transmission". Anaesthesia & Intensive Care Medicine 9, n.º 6 (junho de 2008): 256–58. http://dx.doi.org/10.1016/j.mpaic.2008.04.005.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
13

Fletcher, Allan. "Neuromuscular function and transmission". Anaesthesia & Intensive Care Medicine 12, n.º 6 (junho de 2011): 245–48. http://dx.doi.org/10.1016/j.mpaic.2011.03.012.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
14

MAELICKE, ALFRED, T. COBAN, A. SCHRATTENHOLZ, B. SCHRÖDER, S. REINHARDT-MAELICKE, A. STORCH, J. GODOVAC-ZIMMERMANN, CHRISTOPH METHFESSEL, E. F. R. PEREIRA e EDSON X. ALBUQUERQUE. "Physostigmine and Neuromuscular Transmission". Annals of the New York Academy of Sciences 681, n.º 1 Myasthenia Gr (junho de 1993): 140–54. http://dx.doi.org/10.1111/j.1749-6632.1993.tb22880.x.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
15

Martin, A. Robert. "Principles of Neuromuscular Transmission". Hospital Practice 27, n.º 8 (15 de agosto de 1992): 147–58. http://dx.doi.org/10.1080/21548331.1992.11705473.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
16

Torda, T. A. "Book Review: Neuromuscular Transmission." Anaesthesia and Intensive Care 29, n.º 4 (agosto de 2001): 439. http://dx.doi.org/10.1177/0310057x0102900420.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
17

Hirst, G. D. S., S. De Gleria e D. F. van Helden. "Neuromuscular transmission in arterioles". Experientia 41, n.º 7 (julho de 1985): 874–79. http://dx.doi.org/10.1007/bf01970004.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
18

Sherman, Howard B. "Electromyography: Neuromuscular transmission studies". Surgical Neurology 31, n.º 2 (fevereiro de 1989): 163. http://dx.doi.org/10.1016/0090-3019(89)90336-4.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
19

Schelhaas, H. Jurgen, Bart P. C. Van De Warrenburg, Hubertus P. H. Kremer e Machiel J. Zwarts. "Neuromuscular transmission in SCA6". Annals of Neurology 55, n.º 3 (2004): 451–52. http://dx.doi.org/10.1002/ana.20015.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
20

Pascuzzi, Robert. "Introduction to the Neuromuscular Junction and Neuromuscular Transmission". Seminars in Neurology 10, n.º 01 (março de 1990): 1–5. http://dx.doi.org/10.1055/s-2008-1041246.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
21

UEDA, NAOYUKI. "Clinical Assessment of Neuromuscular Transmission." JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA 15, n.º 3 (1995): 197–201. http://dx.doi.org/10.2199/jjsca.15.197.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
22

Vincent, Angela. "Autoantibodies in neuromuscular transmission disorders". Annals of Indian Academy of Neurology 11, n.º 3 (2008): 140. http://dx.doi.org/10.4103/0972-2327.42932.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
23

Fagerlund, M. J., e L. I. Eriksson. "Current concepts in neuromuscular transmission". British Journal of Anaesthesia 103, n.º 1 (julho de 2009): 108–14. http://dx.doi.org/10.1093/bja/aep150.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
24

Marshall, Ian G. "Prejunctional aspects of neuromuscular transmission". Current Opinion in Anaesthesiology 4, n.º 4 (agosto de 1991): 577–82. http://dx.doi.org/10.1097/00001503-199108000-00021.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
25

Martyn, J. A. J., M. Jonsson Fagerlund e L. I. Eriksson. "Basic principles of neuromuscular transmission". Anaesthesia 64 (março de 2009): 1–9. http://dx.doi.org/10.1111/j.1365-2044.2008.05865.x.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
26

Engel, Andrew. "Congenital Disorders of Neuromuscular Transmission". Seminars in Neurology 10, n.º 01 (março de 1990): 12–26. http://dx.doi.org/10.1055/s-2008-1041248.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
27

Lange, D. J. "Electrophysiologic testing of neuromuscular transmission". Neurology 48, Supplement 5 (1 de abril de 1997): 18S—22S. http://dx.doi.org/10.1212/wnl.48.suppl_5.18s.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
28

Sieb, J. P. "Fluoroquinolone antibiotics block neuromuscular transmission". Neurology 50, n.º 3 (1 de março de 1998): 804–7. http://dx.doi.org/10.1212/wnl.50.3.804.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
29

JONES, R. M. "Neuromuscular transmission and its blockade." Anaesthesia 40, n.º 10 (outubro de 1985): 964–76. http://dx.doi.org/10.1111/j.1365-2044.1985.tb10551.x.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
30

Schulze, J., M. Toepfer, K.-C. Schroff, S. Aschhoff, J. Remien, W. Müller-Felber e S. Endres. "Clindamycin and nicotinic neuromuscular transmission". Lancet 354, n.º 9192 (novembro de 1999): 1792–93. http://dx.doi.org/10.1016/s0140-6736(99)02881-0.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
31

Enomoto, Koh-Ichi, e Charles Edwards. "Thiamine blockade of neuromuscular transmission". Brain Research 358, n.º 1-2 (dezembro de 1985): 316–23. http://dx.doi.org/10.1016/0006-8993(85)90976-x.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
32

Kaminski, Henry J., e Robert L. Ruff. "Congenital Disorders of Neuromuscular Transmission". Hospital Practice 27, n.º 9 (15 de setembro de 1992): 73–85. http://dx.doi.org/10.1080/21548331.1992.11705484.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
33

Mahadeva, Branavan, Lawrence Phillips e Vern Juel. "Autoimmune Disorders of Neuromuscular Transmission". Seminars in Neurology 28, n.º 2 (abril de 2008): 212–27. http://dx.doi.org/10.1055/s-2008-1062260.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
34

Saldien, V., e K. M. Vermeyen. "Neuromuscular transmission monitoring in children". Pediatric Anesthesia 14, n.º 4 (abril de 2004): 289–92. http://dx.doi.org/10.1046/j.1460-9592.2003.01152.x.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
35

Sieb, Jo¨rn P., e Andrew G. Engel. "Ephedrine: effects on neuromuscular transmission". Brain Research 623, n.º 1 (setembro de 1993): 167–71. http://dx.doi.org/10.1016/0006-8993(93)90025-i.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
36

Sanders, D. B. "WS6-1 Neuromuscular transmission — overview". Clinical Neurophysiology 121 (outubro de 2010): S79. http://dx.doi.org/10.1016/s1388-2457(10)60335-5.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
37

Jozefowicz, Ralph F. "Disorders of Neuromuscular Junction Transmission". Guthrie Journal 58, n.º 1 (janeiro de 1989): 5–14. http://dx.doi.org/10.3138/guthrie.58.1.005.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
38

Kurenkov, D. A., S. Yu Chizhevskaya e E. M. Nikolaenko. "Objective monitoring of neuromuscular transmission in laparoscopic surgery". Kazan medical journal 94, n.º 6 (15 de dezembro de 2013): 866–69. http://dx.doi.org/10.17816/kmj1808.

Texto completo da fonte
Resumo:
Aim. To assess the importance of quantitative neuromuscular transmission monitoring in laparoscopic surgery. Methods. 30 patients [11 (37.7%) males, 19 (63.3%) females, mean age 52.3±7.18 years] who underwent laparoscopic surgery and general anesthesia associated with skeletal muscles relaxation, were examined. The degree of neuromuscular transmission recovery and time to trachea extubation performed by an anesthetist after the end of surgery (like laparoscopic cholecystectomy, appendectomy) and general anesthesia associated with skeletal muscles relaxation were assessed using quantitative monitoring of neuromuscular transmission and «blind» control. Results. In 21 patients no drugs were used to reverse the skeletal muscles relaxation. Trachea extubation in this group was performed 10.5 minutes after the end of surgery in average at the neuromuscular transmission Train of Four (TOF) level of 43-81% for 15 patients and at the TOF level over 90% in 6 patients. In 9 patients, sugammadex (2 mg/kg) was used for neuromuscular transmission reversal, the average level of neuromuscular blockade (TOF) in those patients was 41±6.5%. TOF average recovery time up to 90% was 1 minute 48 seconds. Trachea extubation was performed no later than 4 minutes after the sugammadex administration. Conclusion. The subjective assessment of neuromuscular transmission recovery, based on the assessment of clinical signs, is not able to completely exclude the residual muscle relaxation. Objective monitoring of neuromuscular transmission is required to determine the time of intubation, administration of maintenance doses of muscle relaxants, and for assessment of efficacy of reversal and possibility for trachea extubation.
Estilos ABNT, Harvard, Vancouver, APA, etc.
39

Ermilov, Leonid G., Juan N. Pulido, Fawn W. Atchison, Wen-Zhi Zhan, Mark H. Ereth, Gary C. Sieck e Carlos B. Mantilla. "Impairment of diaphragm muscle force and neuromuscular transmission after normothermic cardiopulmonary bypass: effect of low-dose inhaled CO". American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 298, n.º 3 (março de 2010): R784—R789. http://dx.doi.org/10.1152/ajpregu.00737.2009.

Texto completo da fonte
Resumo:
Cardiopulmonary bypass (CPB) is associated with significant postoperative morbidity, but its effects on the neuromuscular system are unclear. Recent studies indicate that even relatively short periods of mechanical ventilation result in significant neuromuscular effects. Carbon monoxide (CO) has gained recent attention as therapy to reduce the deleterious effects of CPB. We hypothesized that 1) CPB results in impaired neuromuscular transmission and reduced diaphragm force generation; and 2) CO treatment during CPB will mitigate these effects. In adult male Sprague-Dawley rats, diaphragm muscle-specific force and neuromuscular transmission properties were measured 90 min after weaning from normothermic CPB (1 h). During CPB, either low-dose inhaled CO (250 ppm) or air was administered. The short period of mechanical ventilation used in the present study (∼3 h) did not adversely affect diaphragm muscle contractile properties or neuromuscular transmission. CPB elicited a significant decrease in isometric diaphragm muscle-specific force compared with time-matched, mechanically ventilated rats (∼25% decline in both twitch and tetanic force). Diaphragm muscle fatigability to 40-Hz repetitive stimulation did not change significantly. Neuromuscular transmission failure during repetitive activation was 60 ± 2% in CPB animals compared with 76 ± 4% in mechanically ventilated rats ( P < 0.05). CO treatment during CPB abrogated the neuromuscular effects of CPB, such that diaphragm isometric twitch force and neuromuscular transmission were no longer significantly different from mechanically ventilated rats. Thus, CPB has important detrimental effects on diaphragm muscle contractility and neuromuscular transmission that are largely mitigated by CO treatment. Further studies are needed to ascertain the underlying mechanisms of CPB-induced neuromuscular dysfunction and to establish the potential role of CO therapy.
Estilos ABNT, Harvard, Vancouver, APA, etc.
40

Fogarty, Matthew J., Maria A. Gonzalez Porras, Carlos B. Mantilla e Gary C. Sieck. "Diaphragm neuromuscular transmission failure in aged rats". Journal of Neurophysiology 122, n.º 1 (1 de julho de 2019): 93–104. http://dx.doi.org/10.1152/jn.00061.2019.

Texto completo da fonte
Resumo:
In aging Fischer 344 rats, phrenic motor neuron loss, neuromuscular junction abnormalities, and diaphragm muscle (DIAm) sarcopenia are present by 24 mo of age, with larger fast-twitch fatigue-intermediate (type FInt) and fast-twitch fatigable (type FF) motor units particularly vulnerable. We hypothesize that in old rats, DIAm neuromuscular transmission deficits are specific to type FInt and/or FF units. In phrenic nerve/DIAm preparations from rats at 6 and 24 mo of age, the phrenic nerve was supramaximally stimulated at 10, 40, or 75 Hz. Every 15 s, the DIAm was directly stimulated, and the difference in forces evoked by nerve and muscle stimulation was used to estimate neuromuscular transmission failure. Neuromuscular transmission failure in the DIAm was observed at each stimulation frequency. In the initial stimulus trains, the forces evoked by phrenic nerve stimulation at 40 and 75 Hz were significantly less than those evoked by direct muscle stimulation, and this difference was markedly greater in 24-mo-old rats. During repetitive nerve stimulation, neuromuscular transmission failure at 40 and 75 Hz worsened to a greater extent in 24-mo-old rats compared with younger animals. Because type IIx and/or IIb DIAm fibers (type FInt and/or FF motor units) display greater susceptibility to neuromuscular transmission failure at higher frequencies of stimulation, these data suggest that the age-related loss of larger phrenic motor neurons impacts nerve conduction to muscle at higher frequencies and may contribute to DIAm sarcopenia in old rats. NEW & NOTEWORTHY Diaphragm muscle (DIAm) sarcopenia, phrenic motor neuron loss, and perturbations of neuromuscular junctions (NMJs) are well described in aged rodents and selectively affect FInt and FF motor units. Less attention has been paid to the motor unit-specific aspects of nerve-muscle conduction. In old rats, increased neuromuscular transmission failure occurred at stimulation frequencies where FInt and FF motor units exhibit conduction failures, along with decreased apposition of pre- and postsynaptic domains of DIAm NMJs of these units.
Estilos ABNT, Harvard, Vancouver, APA, etc.
41

Krivoi, Igor, e Alexey Petrov. "Cholesterol and the Safety Factor for Neuromuscular Transmission". International Journal of Molecular Sciences 20, n.º 5 (28 de fevereiro de 2019): 1046. http://dx.doi.org/10.3390/ijms20051046.

Texto completo da fonte
Resumo:
A present review is devoted to the analysis of literature data and results of own research. Skeletal muscle neuromuscular junction is specialized to trigger the striated muscle fiber contraction in response to motor neuron activity. The safety factor at the neuromuscular junction strongly depends on a variety of pre- and postsynaptic factors. The review focuses on the crucial role of membrane cholesterol to maintain a high efficiency of neuromuscular transmission. Cholesterol metabolism in the neuromuscular junction, its role in the synaptic vesicle cycle and neurotransmitter release, endplate electrogenesis, as well as contribution of cholesterol to the synaptogenesis, synaptic integrity, and motor disorders are discussed.
Estilos ABNT, Harvard, Vancouver, APA, etc.
42

Grishin, S. N., A. E. Khairullin, A. Y. Teplov e M. A. Mukhamedyarov. "Neuromuscular Transmission in a Barium Environment". Biophysics 67, n.º 3 (junho de 2022): 457–60. http://dx.doi.org/10.1134/s000635092203006x.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
43

Stanec, A., e T. Baker. "Physiology and pharmacology of neuromuscular transmission". Current Opinion in Anaesthesiology 2, n.º 4 (agosto de 1989): 470–73. http://dx.doi.org/10.1097/00001503-198908000-00018.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
44

Engbæk, J. "Measurement and monitoring of neuromuscular transmission". Current Opinion in Anaesthesiology 3, n.º 4 (agosto de 1990): 625–29. http://dx.doi.org/10.1097/00001503-199003040-00022.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
45

Engbæk, J. "Measurement and monitoring of neuromuscular transmission". Current Opinion in Anaesthesiology 3, n.º 4 (agosto de 1990): 625–29. http://dx.doi.org/10.1097/00001503-199008000-00022.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
46

Kopman, David, e Cynthia A. Lien. "Physiology and Pharmacology of Neuromuscular Transmission". ASA Refresher Courses in Anesthesiology 37, n.º 1 (julho de 2009): 107–17. http://dx.doi.org/10.1097/asa.0b013e3181a6898d.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
47

Ertas, Mustafa, e M. Baris Baslo. "Abnormal Neuromuscular Transmission in Cluster Headache". Headache: The Journal of Head and Face Pain 43, n.º 6 (junho de 2003): 616–20. http://dx.doi.org/10.1046/j.1526-4610.2003.03103.x.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
48

LOAN, P. B., L. D. PAXTON, R. K. MIRAKHUR, F. M. CONNOLLY e E. P. McCOY. "The TOF-Guard neuromuscular transmission monitor." Anaesthesia 50, n.º 8 (agosto de 1995): 699–702. http://dx.doi.org/10.1111/j.1365-2044.1995.tb06097.x.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
49

Ross, R. "Neuromuscular transmission in the 17th century". Journal of Neurology, Neurosurgery & Psychiatry 51, n.º 10 (1 de outubro de 1988): 1268. http://dx.doi.org/10.1136/jnnp.51.10.1268.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
50

Klose, M. K. "Stress-Induced Thermoprotection of Neuromuscular Transmission". Integrative and Comparative Biology 44, n.º 1 (1 de fevereiro de 2004): 14–20. http://dx.doi.org/10.1093/icb/44.1.14.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
Você também pode estar interessado em listas de outros tipos de fontes sobre o assunto "Neuromuscular transmission":
Teses / dissertações Livros
Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!

Vá para a bibliografia